{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:11:21Z","timestamp":1783350681737,"version":"3.54.6"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"State Key Laboratory of Pathogenesis, Prevention and Treatment of Central Asia High Incidence Diseases fund","award":["SKL-HIDCA-2020-SG5"],"award-info":[{"award-number":["SKL-HIDCA-2020-SG5"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:p>Metabolic syndrome is associated with persistent low-grade inflammation. The advanced lung cancer inflammation index (ALI) is a comprehensive index that measures inflammation. The purpose of this study was to determine the relationship between ALI and all-cause, cardiovascular, and cancer mortality in a metabolic syndrome (MetS) population. We extracted cohort data from the 2007\u20132018 National Health and Nutrition Examination Survey for analysis. Weighted Kaplan\u2013Meier analyses and multivariate adjusted Cox analyses were employed to evaluate the association between ALI and mortality due to all causes, cardiovascular diseases, and cancer in individuals with MetS. Nonlinear relationships were assessed using restricted cubic spline analysis. Subgroup and interaction analyses were conducted to enhance result robustness. This study enrolled 3110 participants, with 366 deaths from all-cause, 92 deaths due to cardiovascular diseases, and 98 deaths related to cancer during the 81-month follow-up period. The population was stratified into 4 groups based on ALI quartiles. After adjusting for covariates, the analysis revealed a significantly reduced risk of all-cause mortality in (Q2, Q3), and Q4 group compared to the reference group (Q1). Similarly, a decreased risk of cardiovascular disease mortality was observed in association with ALI in Q2 and Q3 group compared to the reference group. Stratified analyses further show the robustness of these relationships. In addition, this research also reveals that in the MetS population\u2005\u2265\u200560 years of age, Q2 group is associated with a lower risk of cancer mortality than Q1 group. The restricted cubic spline analyses further revealed a nonlinear association between ALI and all-cause mortality in the MetS population, while demonstrating a linear association with cardiovascular mortality and cancer mortality. ALI is a reliable biomarker of systemic inflammation in the MetS population. In individuals with MetS, reduced levels of ALI are strongly associated with an increased risk of all-cause and cardiovascular mortality, as well as increased cancer mortality in those aged\u2005&gt;\u200560 years.<\/jats:p>","DOI":"10.1097\/md.0000000000045946","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:02:14Z","timestamp":1764169334000},"page":"e45946","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Correlation of advanced lung cancer inflammation index with all-cause, cardiovascular, and cancer mortality in individuals with metabolic syndrome: Evidence from NHANES 2007\u20132018"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6814-5438","authenticated-orcid":false,"given":"Long","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Sheng","family":"LI","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Chao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260514","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: updates on pathophysiology and management in 2021.","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"e230066","DOI":"10.1530\/JME-23-0066","article-title":"Vascular endothelial mineralocorticoid receptors and epithelial sodium channels in metabolic syndrome and related cardiovascular disease.","volume":"71","author":"Jia","year":"2023","journal-title":"J Mol Endocrinol"},{"key":"R3-20260514","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.3390\/nu15204342","article-title":"Non-traditional cardiovascular risk factors in adolescents with obesity and metabolic syndrome may predict future cardiovascular disease.","volume":"15","author":"Tragomalou","year":"2023","journal-title":"Nutrients"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/MOU.0000000000001041","article-title":"Metabolic syndrome, obesity and cancer risk.","volume":"32","author":"Belladelli","year":"2022","journal-title":"Curr Opin Urol"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"316","DOI":"10.23736\/S0031-0808.22.04641-9","article-title":"Metabolic syndrome and bladder cancer.","volume":"64","author":"Righetto","year":"2022","journal-title":"Panminerva Med"},{"key":"R6-20260514","doi-asserted-by":"crossref","first-page":"359","DOI":"10.23736\/S0031-0808.21.04511-0","article-title":"Metabolic syndrome and prostate cancer treatment.","volume":"64","author":"Morlacco","year":"2022","journal-title":"Panminerva Med"},{"key":"R7-20260514","doi-asserted-by":"crossref","first-page":"629666","DOI":"10.3389\/fonc.2021.629666","article-title":"Metabolic syndrome and breast cancer: prevalence, treatment response, and prognosis.","volume":"11","author":"Dong","year":"2021","journal-title":"Front Oncol"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12672-022-00599-7","article-title":"Metabolic syndrome and thyroid cancer: risk, prognosis, and mechanism.","volume":"14","author":"Li","year":"2023","journal-title":"Discov Oncol"},{"key":"R9-20260514","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-023-04062-1","article-title":"Emerging healthy lifestyle factors and all-cause mortality among people with metabolic syndrome and metabolic syndrome-like characteristics in NHANES.","volume":"21","author":"Niu","year":"2023","journal-title":"J Transl Med"},{"key":"R10-20260514","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"e0269550","DOI":"10.1371\/journal.pone.0269550","article-title":"Associations of metabolic syndrome and metabolically unhealthy obesity with cancer mortality: the Japan Multi-Institutional Collaborative Cohort (J-MICC) study.","volume":"17","author":"Nguyen","year":"2022","journal-title":"PLoS One"},{"key":"R12-20260514","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-018-5056-8","article-title":"Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.","volume":"174","author":"Dibaba","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"R13-20260514","first-page":"127","article-title":"Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.","volume":"28","author":"Gathirua-Mwangi","year":"2017","journal-title":"Cancer Causes Control"},{"key":"R14-20260514","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.3390\/jcm12113818","article-title":"A comprehensive summary of the current understanding of the relationship between severe obesity, metabolic syndrome, and inflammatory status.","volume":"12","author":"Ion","year":"2023","journal-title":"J Clin Med"},{"key":"R15-20260514","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10753-021-01549-1","article-title":"Inflammatory biomarkers and components of metabolic syndrome in adolescents: a systematic review.","volume":"45","author":"de F Rocha","year":"2022","journal-title":"Inflammation"},{"key":"R16-20260514","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.hrtlng.2020.05.010","article-title":"The health outcomes of inflammation and obesity in patients with heart failure.","volume":"49","author":"Saleh","year":"2020","journal-title":"Heart Lung"},{"key":"R17-20260514","doi-asserted-by":"crossref","first-page":"1295377","DOI":"10.3389\/fimmu.2023.1295377","article-title":"Association of inflammatory indicators with intensive care unit mortality in critically ill patients with coronary heart disease.","volume":"14","author":"Cheng","year":"2023","journal-title":"Front Immunol"},{"key":"R18-20260514","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2407-13-158","article-title":"Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.","volume":"13","author":"Jafri","year":"2013","journal-title":"BMC Cancer"},{"key":"R19-20260514","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12957-023-02972-4","article-title":"The advanced lung cancer inflammation index is a prognostic factor for gastrointestinal cancer patients undergoing surgery: a systematic review and meta-analysis.","volume":"21","author":"Liu","year":"2023","journal-title":"World J Surg Oncol"},{"key":"R20-20260514","doi-asserted-by":"crossref","first-page":"1074672","DOI":"10.3389\/fphys.2023.1074672","article-title":"Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999-2018.","volume":"14","author":"Tu","year":"2023","journal-title":"Front Physiol"},{"key":"R21-20260514","doi-asserted-by":"crossref","first-page":"1298345","DOI":"10.3389\/fendo.2023.1298345","article-title":"Relationship between advanced lung cancer inflammation index and long-term all-cause, cardiovascular, and cancer mortality among type 2 diabetes mellitus patients: NHANES, 1999-2018.","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R22-20260514","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement.","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R23-20260514","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3390\/jcm14072402","article-title":"Developmental trends of metabolic syndrome in the past two decades: a narrative review.","volume":"14","author":"Obeidat","year":"2025","journal-title":"J Clin Med"},{"key":"R24-20260514","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3390\/ijms26052174","article-title":"Link between metabolic syndrome, inflammation, and eye diseases.","volume":"26","author":"Pie\u0144czykowska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R25-20260514","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2174\/0118715303385742250610120711","article-title":"The inflammatory response in metabolic syndrome.","volume":"25","author":"Mart\u00ednez-P\u00e9rez","year":"2025","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R26-20260514","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40618-014-0209-z","article-title":"Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system.","volume":"38","author":"Azhar","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"R27-20260514","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2174\/0929867327666200824112056","article-title":"Obesity and insulin resistance: associations with chronic inflammation, genetic and epigenetic factors.","volume":"28","author":"Gasmi","year":"2021","journal-title":"Curr Med Chem"},{"key":"R28-20260514","doi-asserted-by":"crossref","first-page":"110691","DOI":"10.1016\/j.diabres.2023.110691","article-title":"Association between obesity, inflammation and insulin resistance: insights into signaling pathways and therapeutic interventions.","volume":"200","author":"Suren Garg","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"R29-20260514","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MNH.0000000000000862","article-title":"Targeting inflammation in hypertension.","volume":"32","author":"Deussen","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R30-20260514","doi-asserted-by":"crossref","first-page":"972140","DOI":"10.3389\/fimmu.2022.972140","article-title":"Systemic consequences of abnormal cholesterol handling: interdependent pathways of inflammation and dyslipidemia.","volume":"13","author":"O\u2019Hagan","year":"2022","journal-title":"Front Immunol"},{"key":"R31-20260514","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12944-023-01856-6","article-title":"Low-grade inflammation is associated with a heterogeneous lipoprotein subclass profile in an apparently healthy population sample.","volume":"22","author":"Pontzen","year":"2023","journal-title":"Lipids Health Dis"},{"key":"R32-20260514","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/jcm12031128","article-title":"Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults.","volume":"12","author":"Xia","year":"2023","journal-title":"J Clin Med"},{"key":"R33-20260514","doi-asserted-by":"crossref","first-page":"872512","DOI":"10.3389\/fnut.2022.872512","article-title":"A synergistic association between inflammation, malnutrition, and mortality in patients with diabetics.","volume":"9","author":"Wang","year":"2022","journal-title":"Front Nutr"},{"key":"R34-20260514","doi-asserted-by":"crossref","first-page":"e230026","DOI":"10.20945\/2359-4292-2023-0026","article-title":"Correlation between low handgrip strength and metabolic syndrome in older adults: a systematic review.","volume":"68","author":"d\u2019Avila","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"R35-20260514","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: pathogenesis and clinical significance.","volume":"43","author":"Soeters","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R36-20260514","first-page":"100382","article-title":"The association of Neutrophil-to-Lymphocyte ratio with metabolic syndrome in U.S. Adults: findings from the 1999-2018 National Health and Nutrition Examination survey.","volume":"39","author":"Sarrafan-Chaharsoughi","year":"2025","journal-title":"J Clin Transl Endocrinol"},{"key":"R37-20260514","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3390\/cancers14071622","article-title":"Does inflammation contribute to cancer incidence and mortality during aging? A conceptual review.","volume":"14","author":"Guerville","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:08:21Z","timestamp":1778756901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":37,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045946","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2024-10-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}